Lassen Therapeutics to create anti-IL-11 antibody for cancer and fibrosis
Lassen Therapeutics is revealing USD 31 million from Frazier Healthcare Partners, Alta Venture and Longwood Fund and has an aim to create antibodies for cancer and fibrosis treatment. IL-11, a cytokine that plays a role in both disease areas.
Unlike antibody giant Regeneron, which had to set up its antibody generation platforms, Lassen and its team of seasoned antibody developers are leveraging the platforms developed by others to search and develop antibodies against new targets.
Its initial plan was to create an antibody against IL-11 using those external platforms, but it found out t...
